Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-30 · accession 0001055726-23-000045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-03 | 2023-06-30 | INO | Sumner Michael John | Chief Medical Off | M - OptEx | — | +35.0K | 35.0K | New | — |
| D | 2023-07-03 | 2023-06-30 | INO | Sumner Michael John | Chief Medical Off | M - OptEx | $0.00 | -35.0K | 70.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-30 | M | A | 35,000 | — | 35,000 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 105,000 restricted stock units is as follows: 35,000 shares vested on June 30, 2023; 35,000 shares will vest on June 30, 2024; 35,000 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 2 | Derivative | Restricted Stock Unit | 2023-06-30 | M | D | 35,000 | $0.00 | 70,000 | D | — · — to — | 35,000 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 105,000 restricted stock units is as follows: 35,000 shares vested on June 30, 2023; 35,000 shares will vest on June 30, 2024; 35,000 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |